Conditions: Ocular Inflammation
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 268
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the ocular safety, tolerability, and efficacy of topical administration of ISV-303 compared with DuraSite Vehicle.

Detailed description:

Arms:
arm 1: 0.075% bromfenac in DuraSite vehicle dosed BID arm 2: DuraSite Vehicle dosed BID

Interventions: intervention 1: ISV-303 intervention 2: DuraSite Vehicle
Intervention descriptions: intervention 1: Bromfenac in DuraSite intervention 2: DuraSite Vehicle

Protocol document: